Wockhardt’s Zaynich Secures FDA Approval, India’s Second Homegrown New Drug
Indian pharma firm Wockhardt has received FDA approval for Zaynich, an antibiotic for complicated urinary‑tract infections, becoming only the second novel drug discovered in India to win US clearance. Founder Habil Khorakiwala sees the breakthrough as vindication of an $800 million bet on antibiotic R&D and expects peak global sales of $1.5 billion.